Hosted by Mark Wade of TransPerfect Life Sciences, LifeSci Talks is an informal, informative conversation that focuses on a variety of themes and topics in the life sciences space. Featuring thought leaders and industry experts from different therapeutic areas and divisions, the discussions provide actionable takeaways and topical insights into current global challenges and opportunities.
All content for LifeSci Talks is the property of TransPerfect Life Sciences and is served directly from their servers
with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
Hosted by Mark Wade of TransPerfect Life Sciences, LifeSci Talks is an informal, informative conversation that focuses on a variety of themes and topics in the life sciences space. Featuring thought leaders and industry experts from different therapeutic areas and divisions, the discussions provide actionable takeaways and topical insights into current global challenges and opportunities.
Exploring the Value Add of In-Study Interviews as a critical COA Endpoint
LifeSci Talks
28 minutes 24 seconds
1 year ago
Exploring the Value Add of In-Study Interviews as a critical COA Endpoint
In this episode of TransPerfect LifeSci Talks, Mark Wade, Global Practice Leader at TransPerfect Life Sciences sits down with Tom Willgoss, Patient-Centered Outcomes Research Chapter Lead, UK Site Head for Data Sciences at Roche to discuss the value of understanding and measuring patient experience data throughout the clinical journey. They delve into the significance of patient-centered clinical outcome assessments for endpoint selection in clinical trials, prioritizing diversity and inclusion across global clinical sites with the help of translation services providers, and shifting trends towards DCTs.
LifeSci Talks
Hosted by Mark Wade of TransPerfect Life Sciences, LifeSci Talks is an informal, informative conversation that focuses on a variety of themes and topics in the life sciences space. Featuring thought leaders and industry experts from different therapeutic areas and divisions, the discussions provide actionable takeaways and topical insights into current global challenges and opportunities.
